antibody therapies

Displaying 1 - 9 of 9

Study identifies monoclonal antibodies that may neutralize many norovirus variants

Study identifies monoclonal antibodies that may neutralize many norovirus variants

Related Categories: 
Health and Medicine Research antibody therapies B.V. Venkataram Prasad Baylor College of Medicine gastroenteritis James Crowe Jr. norovirus pathology microbiology and immunology Vanderbilt Vaccine Center

VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody

VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody

Related Categories: 
Press release Evotec Evotec SE Chikungunya Vanderbilt Vaccine Center James E. Crowe Jim Crowe EVT894 chikungunya virus monoclonal antibody antibody therapies

VUMC and AstraZeneca join forces to identify potential COVID-19 treatments

VUMC and AstraZeneca join forces to identify potential COVID-19 treatments

Related Categories: 
antibody therapies AstraZeneca coronavirus COVID-19 Department of Pediatrics James Crowe Jr. Robert Carnahan SARS-CoV-2 Vanderbilt Vaccine Center

Antibody mixture may help block Ebola virus infection

Antibody mixture may help block Ebola virus infection

Related Categories: 
antibody therapies ebola immunity James Crowe Jr. Pavlo Gilchuk Research Vanderbilt Vaccine Center

Antibody isolated at VUMC found to halt dengue virus

An antibody isolated by James Crowe's lab found to halt the human dengue virus.

Related Categories: 
antibody therapies dengue James Crowe Jr. mosquito Pathogens Research Vanderbilt Vaccine Center

New tool may speed antibody, vaccine research

New tool may speed antibody, vaccine research

Related Categories: 
Research antibody therapies computer science Ivelin Georgiev LIBRA-seq pathology microbiology and immunology School of Engineering vaccine development Vanderbilt Vaccine Center

VUMC joins international effort to speed vaccine development

VUMC joins international effort to speed vaccine development

Related Categories: 
James Crowe Jim Crowe antibody therapies Centers for Excellence in Translational Research Crowe Laboratory National Institute for Allergy and Infectious Diseases pathology microbiology and immunology Research vaccine research

Flu’s “hidden target” may lead to universal vaccine: study

Flu’s “hidden target” may lead to universal vaccine: study

Related Categories: 
antibody therapies Cell Flu influenza James Crowe Jr. Scripps Research Institute Vanderbilt Vaccine Center

Designing antibodies to fight the flu

Designing antibodies to fight the flu

Related Categories: 
antibody therapies Department of Chemistry Department of Pediatrics Flu flu vaccine influenza James Crowe Jr. Jens Meiler pathology microbiology and immunology PNAS Vanderbilt Vaccine Center